Tumor Necrosis Factor Superfamily Member APRIL Contributes to Fibrotic Scar Formation After Spinal Cord Injury

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2016 Apr 22

PMID 27098833

Citations 14

Authors

Lucy H Funk

Amber R Hackett

Mary Bartlett Bunge

Jae K Lee

Affiliations

Soon will be listed here.

Abstract

Background: Fibrotic scar formation contributes to the axon growth-inhibitory environment that forms following spinal cord injury (SCI). We recently demonstrated that depletion of hematogenous macrophages led to a reduction in fibrotic scar formation and increased axon growth after SCI. These changes were associated with decreased TNFSF13 (a proliferation inducing ligand (APRIL)) expression, but the role of APRIL in fibrotic scar formation after SCI has not been directly investigated. Thus, the goal of this study was to determine the role of APRIL in fibrotic scar formation after SCI.

Methods: APRIL knockout and wild-type mice received contusive SCI and were assessed for inflammatory cytokine/chemokine expression, leukocyte infiltration, fibrotic scar formation, axon growth, and cell proliferation.

Results: Expression of APRIL and its receptor BCMA is increased following SCI, and genetic deletion of APRIL led to reduced fibrotic scar formation and increased axon growth. However, the fibrotic scar reduction in APRIL KO mice was not a result of changes in fibroblast or astrocyte proliferation. Rather, APRIL knockout mice displayed reduced TNFα and CCL2 expression and less macrophage and B cell infiltration at the injury site.

Conclusions: Our data indicate that APRIL contributes to fibrotic scar formation after SCI by mediating the inflammatory response.

Citing Articles

Galectin-3 inhibition reduces fibrotic scarring and promotes functional recovery after spinal cord injury in mice.

Shan F, Ye J, Xu X, Liang C, Zhao Y, Wang J Cell Biosci. 2024; 14(1):128.

PMID: 39407295 PMC: 11481377. DOI: 10.1186/s13578-024-01310-9.

Characterization of the Expressions and m6A Methylation Modification Patterns of mRNAs and lncRNAs in a Spinal Cord Injury Rat Model.

Liu X, Li Z, Tong J, Wu F, Jin H, Liu K Mol Neurobiol. 2024; 62(1):806-818.

PMID: 38907070 PMC: 11711147. DOI: 10.1007/s12035-024-04297-z.

Daphnoretin inhibited SCI-induced inflammation and activation of NF-κB pathway in spinal dorsal horn.

Wu J, Lin F, Chen B Aging (Albany NY). 2024; 16(11):9680-9691.

PMID: 38843384 PMC: 11210226. DOI: 10.18632/aging.205893.

Role of dendritic cells in spinal cord injury.

Han X, Zhang M, Yan L, Fu Y, Kou H, Shang C CNS Neurosci Ther. 2024; 30(3):e14593.

PMID: 38528832 PMC: 10964036. DOI: 10.1111/cns.14593.

Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway.

Zhang H, Zang C, Zhao W, Zhang L, Liu R, Feng Z Int J Nanomedicine. 2023; 18:7047-7063.

PMID: 38046235 PMC: 10693282. DOI: 10.2147/IJN.S433510.

References

Marsters S, Yan M, Pitti R, Haas P, Dixit V, Ashkenazi A . Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol. 2000; 10(13):785-8. DOI: 10.1016/s0960-9822(00)00566-2. View

Wu Y, Bressette D, CARRELL J, Kaufman T, Feng P, Taylor K . Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem. 2000; 275(45):35478-85. DOI: 10.1074/jbc.M005224200. View

Rennert P, Schneider P, Cachero T, Thompson J, Trabach L, Hertig S . A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med. 2000; 192(11):1677-84. PMC: 2193103. DOI: 10.1084/jem.192.11.1677. View

Stein J, Lopez-Fraga M, Elustondo F, Carvalho-Pinto C, Rodriguez D, Gomez-Caro R . APRIL modulates B and T cell immunity. J Clin Invest. 2002; 109(12):1587-98. PMC: 151011. DOI: 10.1172/JCI15034. View

Deshayes F, Lapree G, Portier A, Richard Y, Pencalet P, Mahieu-Caputo D . Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene. 2003; 23(17):3005-12. DOI: 10.1038/sj.onc.1207350. View

Bartholdi D, Schwab M . Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci. 1997; 9(7):1422-38. DOI: 10.1111/j.1460-9568.1997.tb01497.x. View

Basso D, Fisher L, Anderson A, Jakeman L, McTigue D, Popovich P . Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006; 23(5):635-59. DOI: 10.1089/neu.2006.23.635. View

Lytle J, Wrathall J . Glial cell loss, proliferation and replacement in the contused murine spinal cord. Eur J Neurosci. 2007; 25(6):1711-24. DOI: 10.1111/j.1460-9568.2007.05390.x. View

Donnelly D, Popovich P . Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2007; 209(2):378-88. PMC: 2692462. DOI: 10.1016/j.expneurol.2007.06.009. View

10.

Planelles L, Medema J, Hahne M, Hardenberg G . The expanding role of APRIL in cancer and immunity. Curr Mol Med. 2008; 8(8):829-44. DOI: 10.2174/156652408786733711. View

11.

Mohr E, Serre K, Manz R, Cunningham A, Khan M, Hardie D . Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J Immunol. 2009; 182(4):2113-23. DOI: 10.4049/jimmunol.0802771. View

12.

Kimberley F, van Bostelen L, Cameron K, Hardenberg G, Marquart J, Hahne M . The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J. 2009; 23(5):1584-95. DOI: 10.1096/fj.08-124669. View

13.

Kim K, Park J, Jou I, Park S . Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia. J Leukoc Biol. 2009; 86(2):349-59. DOI: 10.1189/jlb.1008659. View

14.

Lee S, Kim E, Suk K, Lee W . BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB. Inflamm Res. 2011; 60(9):807-15. DOI: 10.1007/s00011-011-0336-3. View

15.

Xu J, Ding W, Shao K, Wang X, Wang G, Li H . Transcription of promoter from the human APRIL gene regulated by Sp1 and NF-kB. Neoplasma. 2012; 59(3):341-7. DOI: 10.4149/neo_2012_044. View

16.

Sorensen Catts V, Weickert C . Gene expression analysis implicates a death receptor pathway in schizophrenia pathology. PLoS One. 2012; 7(4):e35511. PMC: 3335850. DOI: 10.1371/journal.pone.0035511. View

17.

Wang H, Wang K, Zhong X, Qiu W, Dai Y, Wu A . Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse. J Clin Immunol. 2012; 32(5):1007-11. DOI: 10.1007/s10875-012-9709-9. View

18.

Soderblom C, Luo X, Blumenthal E, Bray E, Lyapichev K, Ramos J . Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury. J Neurosci. 2013; 33(34):13882-7. PMC: 3755723. DOI: 10.1523/JNEUROSCI.2524-13.2013. View

19.

Cregg J, DePaul M, Filous A, Lang B, Tran A, Silver J . Functional regeneration beyond the glial scar. Exp Neurol. 2014; 253:197-207. PMC: 3951813. DOI: 10.1016/j.expneurol.2013.12.024. View

20.

Osorio C, Chacon P, White M, Kisiswa L, Wyatt S, Rodriguez-Tebar A . Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRIL. Mol Cell Neurosci. 2014; 59:24-36. PMC: 4008386. DOI: 10.1016/j.mcn.2014.01.002. View